ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:
Browse All Topics

Home

Migraine Therapy

A quick overview of what's new (and what to expect) in migraine prevention. ©IrinaBraga/ Shutterstock

Topics

Browse All Topics
Browse All Content

Recent Content

The Human Epilepsy Project

Jeffrey A. Loeb, MD, PhD
August 21, 2017 | Epilepsy and Seizure
By

Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.

Odor Identification: Marker for Early Alzheimer Disease?

Veronica Hackethal, MD
August 17, 2017 | Parkinson disease
By

OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.

Parkinson Disease: Functional Assessment, Gene Disruptions, and More

Natalie Timoshin
News | August 15, 2017 | Parkinson disease
By

New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.

Migraine Risk Influenced by Extremes of Weight

Mark L. Fuerst
August 15, 2017 | Headache and Migraine
By

Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.

Smartphone Headache Diaries: Privacy Pros and Cons

Blog | August 15, 2017 | Headache and Migraine
By and

Just how private is that information your patient records in a mobile headache diary?

FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review

Natalie Timoshin
August 11, 2017 | Parkinson disease, Multiple sclerosis
By

Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.

Telemedicine in Your Neurology Practice?

Blog | August 11, 2017
By

If you are thinking of adding telemedicine to your practice, here are the benefits—and things to consider.

View More Videos
View More Slideshows

By clicking Accept, you agree to become a member of the UBM Medica Community.